EMA Authorised: Cayston (aztreonam lysine) — Gilead Sciences Ireland UC

View source ↗

Summary

EMA authorised Cayston (aztreonam lysine) from Gilead Sciences Ireland UC for use in cystic fibrosis and related respiratory tract infections, with decision dat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Respiratory Tract Infections

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Status: Authorised. Therapeutic area: Cystic Fibrosis;Respiratory Tract Infections. MAH: Gilead Sciences Ireland UC. Decision date: 09/03/2026